E7070

· Eisai Inc.

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for E7070, covering 2006-10-11 to 2018-07-03. Get the full timeline:

Most recent: Clinical Trial Update: E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes [Phase 2]